Gene Transfer Technologies Market

The report "Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029". is projected to expand to a value of USD 5.93 billion in 2029 from USD 3.73 billion in 2024, with a significant CAGR of 9.7%. Some of the prominent factors driving the growth of market are increasing demand for personalized medicine and cell and gene therapies, and expanding applications in vaccine development, and in cancer immunotherapy.

Browse 771 market data Tables and 56 Figures spread through 524 Pages and in-depth TOC on "Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/gene-transfer-technologies-market-74062902.html

The reagents, kits and assays segment accounted for the dominant share in 2023.

By product, the market is divided into instruments, consumables, reagents, kits & assays, and other products. In 2023, the reagents, kits & assays held the highest market share. Reagents, kits & assays hold a major market share due to the number of clinical trials increased with the high engagement of CROS to support such trials. This is followed by technological advancements toward improving delivery efficiency and scalability, which are gaining in momentum to drive market growth.

In vivo method is likely to grow at significant CAGR during the forecast period for 2024-2029.

Based on the method, the market is divided into ex vivo, in vivo and in vitro. The in vivo method dominated the market in 2023 owing to increased prevalence of genetic disorders and chronic diseases that could heighten demand for innovative therapeutic solutions. Ex vivo method is likely to grow at faster pace owing to commercial success of therapies such as CAR-T cell therapy and stem cell-based treatments for genetic disorders.

North America: The region dominated gene transfer technologies market.

Based on region the gene transfer technologies market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the market owing to presence of key market players, substantial investments in biotechnology and favorable FDA regulation are further likely to give momentum to the market growth. Furthermore, rapid advancements in stem cell therapy research & precision medicine and increasing focus on cell-based and gene therapies are some of the factors spuring growth of the market in North America.

Prominant players operating in the gene transfer technologies market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Qiagen (Netherlands), Sartorious AG (Germany), Bio-Rad Laboratories Inc. (US), Revvity (US), Agilent Technologies, Inc. (US), Genscript (US) and Bio-Techne (US) and among others.

Don’t miss out on business opportunities in Gene Transfer Technologies Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]